ArriVent BioPharma (AVBP) PT Raised to $40 at Citi, Adding 90d Upside Catalyst Watch
Tweet Send to a Friend
Citi analyst Yigal Nochomovitz raised the price target on ArriVent BioPharma (NASDAQ: AVBP) to $40.00 (from $36.00) while maintaining a ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
